Add to ORKGKey steps in the structure-based optimization of the hepatitis C virus NS3/4A protease inhibito
Hepatitis C virus (HCV) has infected millions of people worldwide and emerged as a global health cri...
Hepatitis C virus (HCV) causes acute and chronic liver disease in humans, including chronic hepatiti...
Here we report the discovery of a highly conserved novel binding site located at the interface betwe...
The first structural characterization of the genotype 3a Hepatitis C Virus NS3 protease is reported,...
AbstractAn estimated 1% of the global human population is infected by hepatitis C viruses (HCVs), an...
Hepatitis C NS3/4A protease is a prime therapeutic target that is responsible for cleaving the viral...
Summary. Hepatitis C virus (HCV) nonstructural protein 3-4A (NS3-4A) is a complex composed of NS3 a...
Background: Hepatitis C virus (HCV) currently infects approximately three percent of the world popul...
We recently reported a new class of inhibitors of the chymotrypsin-like serine protease NS3 of the h...
The hepatitis C virus NS3 protein contains a serine protease domain with a chymotrypsin-like fold, w...
Infection of hepatitis C (HCV) is a major threat to human health throughout the world. The current t...
The non-structural protein 3 (NS3) of Hepatitis C virus (HCV) is a bifunctional enzyme with RNA-depe...
Hepatitis C virus non-structural protein 3 contains a serine protease and an RNA helicase. Protease ...
AbstractBackground: Hepatitis C virus (HCV) currently infects approximately 3% of the world's popula...
<div><p>Egypt has the highest prevalence of hepatitis C virus (HCV) infection worldwide with a frequ...
Hepatitis C virus (HCV) has infected millions of people worldwide and emerged as a global health cri...
Hepatitis C virus (HCV) causes acute and chronic liver disease in humans, including chronic hepatiti...
Here we report the discovery of a highly conserved novel binding site located at the interface betwe...
The first structural characterization of the genotype 3a Hepatitis C Virus NS3 protease is reported,...
AbstractAn estimated 1% of the global human population is infected by hepatitis C viruses (HCVs), an...
Hepatitis C NS3/4A protease is a prime therapeutic target that is responsible for cleaving the viral...
Summary. Hepatitis C virus (HCV) nonstructural protein 3-4A (NS3-4A) is a complex composed of NS3 a...
Background: Hepatitis C virus (HCV) currently infects approximately three percent of the world popul...
We recently reported a new class of inhibitors of the chymotrypsin-like serine protease NS3 of the h...
The hepatitis C virus NS3 protein contains a serine protease domain with a chymotrypsin-like fold, w...
Infection of hepatitis C (HCV) is a major threat to human health throughout the world. The current t...
The non-structural protein 3 (NS3) of Hepatitis C virus (HCV) is a bifunctional enzyme with RNA-depe...
Hepatitis C virus non-structural protein 3 contains a serine protease and an RNA helicase. Protease ...
AbstractBackground: Hepatitis C virus (HCV) currently infects approximately 3% of the world's popula...
<div><p>Egypt has the highest prevalence of hepatitis C virus (HCV) infection worldwide with a frequ...
Hepatitis C virus (HCV) has infected millions of people worldwide and emerged as a global health cri...
Hepatitis C virus (HCV) causes acute and chronic liver disease in humans, including chronic hepatiti...
Here we report the discovery of a highly conserved novel binding site located at the interface betwe...